PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 16 filers reported holding PLX PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5 | -44.4% | 37,000 | -32.1% | 0.00% | – |
Q4 2022 | $9 | -100.0% | 54,500 | -73.9% | 0.00% | -100.0% |
Q2 2021 | $2,884,000 | +14.7% | 208,983 | -25.0% | 0.00% | +33.3% |
Q1 2021 | $2,515,000 | +227.5% | 278,551 | +100.3% | 0.00% | +200.0% |
Q4 2020 | $768,000 | +206.0% | 139,083 | +79.0% | 0.00% | – |
Q3 2020 | $251,000 | +4.6% | 77,683 | +5.0% | 0.00% | – |
Q2 2020 | $240,000 | +43.7% | 73,983 | -0.6% | 0.00% | – |
Q1 2020 | $167,000 | -45.4% | 74,400 | +6.1% | 0.00% | – |
Q4 2019 | $306,000 | -12.6% | 70,111 | +2.0% | 0.00% | – |
Q3 2019 | $350,000 | -24.9% | 68,711 | +6.2% | 0.00% | – |
Q2 2019 | $466,000 | +51.3% | 64,711 | +10.4% | 0.00% | – |
Q1 2019 | $308,000 | +359.7% | 58,612 | +34.1% | 0.00% | – |
Q4 2018 | $67,000 | -60.4% | 43,712 | +4.8% | 0.00% | – |
Q3 2018 | $169,000 | -39.9% | 41,712 | -46.2% | 0.00% | – |
Q2 2018 | $281,000 | +119.5% | 77,524 | +102.9% | 0.00% | – |
Q1 2018 | $128,000 | -42.9% | 38,212 | +17.5% | 0.00% | – |
Q4 2017 | $224,000 | +54.5% | 32,512 | +44.4% | 0.00% | – |
Q3 2017 | $145,000 | – | 22,512 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 1,875,000 | $7,575,000 | 0.41% |
Ground Swell Capital, LLC | 31,150 | $126,000 | 0.32% |
Park West Asset Management LLC | 1,473,218 | $5,952,000 | 0.21% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $253,000 | 0.13% |
O'Brien Greene & Co. Inc | 60,340 | $244,000 | 0.08% |
Eidelman Virant Capital | 27,000 | $109,000 | 0.06% |
MBL Wealth, LLC | 52,000 | $210,000 | 0.05% |
Shay Capital LLC | 88,620 | $358,000 | 0.05% |
EXANE DERIVATIVES | 13,407 | $54,161,000 | 0.02% |
GW&K Investment Management, LLC | 428,171 | $1,730,000 | 0.02% |